NCT05172687View on ClinicalTrials.gov

The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia

CompletedOBSERVATIONAL
Enrollment

336,460

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Alzheimer DiseaseDementiaPrescribing, Off-Label
Interventions
BEHAVIORAL

Overprescribing letter to attributed physician

Letter telling patient's attributed physician they were under review for high prescribing

BEHAVIORAL

Placebo letter to attributed physician

Letter to patient's attributed physician about unrelated Medicare regulation

Trial Locations (3)

10032

Columbia University, New York

02115

Harvard T.H. Chan School of Public Health, Boston

02138

National Bureau of Economic Research, Cambridge

All Listed Sponsors
collaborator

National Bureau of Economic Research, Inc.

OTHER

collaborator

Harvard School of Public Health (HSPH)

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Columbia University

OTHER

NCT05172687 - The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia | Biotech Hunter | Biotech Hunter